News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
597,685 Results
Type
Article (55310)
Company Profile (228)
Press Release (542147)
Section
Business (164386)
Career Advice (2437)
Deals (30234)
Drug Delivery (108)
Drug Development (78042)
Employer Resources (150)
FDA (16187)
Job Trends (13507)
News (296852)
Policy (31827)
Tag
Academia (2573)
Alliances (42061)
Alzheimer's disease (1294)
Approvals (16095)
Artificial intelligence (133)
Bankruptcy (312)
Best Places to Work (10507)
Biotechnology (167)
Breast cancer (131)
Cancer (1174)
Cardiovascular disease (100)
Career advice (2039)
Cell therapy (250)
Clinical research (61585)
Collaboration (372)
Compensation (198)
COVID-19 (2620)
C-suite (94)
Data (1098)
Diabetes (155)
Diagnostics (5865)
Drug pricing (97)
Earnings (62927)
Employer resources (138)
Events (88847)
Executive appointments (289)
FDA (16726)
Funding (326)
Gene therapy (188)
GLP-1 (649)
Government (4233)
Healthcare (17051)
Infectious disease (2709)
Inflammatory bowel disease (109)
Interviews (452)
IPO (14770)
Job creations (3367)
Job search strategy (1705)
Layoffs (464)
Legal (7441)
Lung cancer (190)
Manufacturing (178)
Medical device (11717)
Medtech (11720)
Mergers & acquisitions (15535)
Metabolic disorders (445)
Neuroscience (1569)
NextGen Class of 2024 (5646)
Non-profit (4060)
Northern California (1422)
Obesity (261)
Opinion (202)
Patents (107)
People (47832)
Phase I (19067)
Phase II (26795)
Phase III (20845)
Pipeline (457)
Postmarket research (2607)
Preclinical (8104)
Radiopharmaceuticals (253)
Rare diseases (229)
Real estate (4866)
Regulatory (21528)
Research institute (2343)
Resumes & cover letters (405)
Southern California (1222)
Startups (3077)
United States (12631)
Vaccines (634)
Weight loss (212)
Date
Today (108)
Last 7 days (717)
Last 30 days (3696)
Last 365 days (34112)
2024 (31263)
2023 (37948)
2022 (48572)
2021 (52306)
2020 (49622)
2019 (41270)
2018 (31196)
2017 (30732)
2016 (29412)
2015 (32878)
2014 (26168)
2013 (21822)
2012 (23245)
2011 (23518)
2010 (22038)
Location
Africa (769)
Arizona (149)
Asia (35508)
Australia (6421)
California (3140)
Canada (1089)
China (225)
Colorado (134)
Connecticut (156)
Europe (84902)
Florida (434)
Georgia (103)
Illinois (304)
Indiana (176)
Kansas (88)
Maryland (567)
Massachusetts (2481)
Michigan (126)
Minnesota (241)
New Jersey (884)
New York (896)
North Carolina (711)
Northern California (1422)
Ohio (122)
Pennsylvania (774)
South America (1117)
Southern California (1222)
Texas (474)
Washington State (344)
597,685 Results for "texas children s cancer centre".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, announced that its UCLA research team has created a promising new drug candidate for treating recurrent Ewing sarcoma, a deadly children’s cancer.
April 16, 2024
·
4 min read
Business
New Transformative Leadership Team Announced for Texas Children’s World-Renowned Heart Center
Texas Children’s Hospital is pleased to announce the new executive leadership structure at the Texas Children’s Heart Center, which has been ranked number one in the nation for pediatric cardiology and heart surgery by U.S. News and World Report for seven consecutive years.
May 3, 2024
·
6 min read
Gene therapy
7 Children Receiving Bluebird’s Gene Therapy Developed Blood Cancers: Study
The pediatric patients, with a rare neurodegenerative disease, were treated with bluebird bio’s Skysona to slow the progression of neurologic dysfunction. Six patients developed myelodysplastic syndrome and one patient developed acute myeloid leukemia.
October 10, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Yunu Extends Free Cancer Center Use of Platform for All Children’s Oncology Group Clinical Trials
September 12, 2024
·
3 min read
Press Releases
Lantern Pharma Announces Three U.S. FDA Rare Pediatric Disease Designations Granted to LP-184 in Multiple Ultra Rare Children’s Cancers
September 23, 2024
·
9 min read
BioMidwest
MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting
MAIA Biotechnology, Inc. announced that Dr. Rachid Drissi, Principal Investigator at the Center for Childhood Cancer Research, Nationwide Children’s Hospital, and Associate Professor at Ohio State University, will present an abstract detailing the potency of THIO, MAIA’s telomere-targeting agent, as treatment for pediatric brain cancers at the American Association for Cancer Research Annual Meeting taking place April 5–10, 2024 in San Diego, California.
March 6, 2024
·
6 min read
Biotech Beach
City of Hope Children’s Cancer Center, Children’s Oncology Group conduct largest clinical trial seeking to prevent heart failure among childhood cancer survivors
Physicians at City of Hope, one of the largest cancer research and treatment organizations in the United States, in cooperation with the Children’s Oncology Group (COG), have conducted the largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure.
January 9, 2024
·
7 min read
Business
Eureka Therapeutics Announces UCSF Benioff Children’s Hospitals as First California Site for ARYA-2 Clinical Trial Targeting Pediatric Liver Cancers
Eureka Therapeutics, Inc. today announced the activation of UCSF Benioff Children’s Hospitals as the first California site to join the ARYA-2 clinical trial ( NCT04634357 ).
April 2, 2024
·
3 min read
Pharm Country
Children’s Hospital of Philadelphia Study Reveals Novel Immune-Based Biomarker Helps Detect Ovarian Cancer Two to Four Years Before Conventional Diagnosis
Researchers at Children’s Hospital of Philadelphia (CHOP) announced the discovery of a novel immune-based biomarker that could pave the way for potential lifesaving early detection of high-grade ovarian cancer (HGOC).
June 14, 2024
·
4 min read
Genetown
Inozyme Pharma Announces Presentation and Sponsored Symposium at the 11th International Conference on Children’s Bone Health (ICCBH)
Inozyme Pharma, Inc. announced a data presentation and sponsored symposium at the 11th International Conference on Children’s Bone Health, which is being held June 22-25, 2024, in Salzburg, Austria.
June 21, 2024
·
3 min read
1 of 59,769
Next